Status:
COMPLETED
Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject
Lead Sponsor:
Medy-Tox
Conditions:
Overweight
Eligibility:
All Genders
19-70 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of LMT1-48(Probiotics) compared to a placebo in reducing the body fat in overweight subjects
Eligibility Criteria
Inclusion
- Age between 19 and 70 years
- Overweight (25 kg/m2 ≤ body mass index (BMI) \< 30 kg/m2)
Exclusion
- Pregnancy or breast-feeding
- Unstable body weight (body weight change \> 10% within 3 months before screening)
Key Trial Info
Start Date :
September 4 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 7 2020
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT03759743
Start Date
September 4 2018
End Date
January 7 2020
Last Update
July 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Seongnam-si, South Korea